Lifestyle induced weight loss and Liraglutide in the treatment of non-alcoholic steatohepatitis (NASH)
Latest Information Update: 16 Jul 2020
At a glance
- Drugs Liraglutide (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
Most Recent Events
- 16 Jul 2020 Status changed from recruiting to discontinued.
- 13 Feb 2019 New trial record